Hjem › Kronisk inflammatorisk demyeliniserende polyradikuloneuropati › New York
Kronisk inflammatorisk demyeliniserende polyradikuloneuropati kliniske forsøg i New York
8 studier for Kronisk inflammatorisk demyeliniserende polyradikuloneuropati søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1605, New York
- Site Number - 1627, New York
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07032662Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- South Shore Neurologic Associates - Patchogue, Patchogue
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT05327114A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Dent Neurologic Institute - Amherst- Site Number : 8400039, Amherst
- Hospital for Special Surgery - Site Number : 8400041, New York
- Columbia University Irving Medical Center- Site Number : 8400003, New York
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06290141A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, New York
- TG Therapeutics Investigational Trial Site, Rochester
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06680037A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- GC2402 Study Site 110, New York
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, New York
- Clinical Study Site, New York
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT06858579A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Columbia University Irving Medical Center, New York
RekruttererFase 1
Alder 18 til 75 · Alle køn · Opdateret 14. aug. 2026 · NCT07304154A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- NYU Langone Health, New York
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 20. jan. 2026 · NCT06747351Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.